SETD7 and colorectal carcinoma: Our previous study found that SETD7 promotes HCT116 and RKO cell proliferation and inhibits apoptosis in human colorectal cancer (CRC), which can serve as a potential diagnostic and prognostic biomarker for CRC 14.